First Time Loading...

Patrys Ltd
ASX:PAB

Watchlist Manager
Patrys Ltd Logo
Patrys Ltd
ASX:PAB
Watchlist
Price: 0.0075 AUD 7.14% Market Closed
Updated: May 17, 2024

Patrys Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Patrys Ltd
Revenue Peer Comparison

Comparables:
IMM
MSB
CSL
CUV
TLX

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Patrys Ltd
ASX:PAB
Revenue
AU$1.7m
CAGR 3-Years
25%
CAGR 5-Years
27%
CAGR 10-Years
9%
Immutep Ltd
ASX:IMM
Revenue
AU$256.6k
CAGR 3-Years
-61%
CAGR 5-Years
-45%
CAGR 10-Years
-24%
Mesoblast Ltd
ASX:MSB
Revenue
$7.5m
CAGR 3-Years
-23%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Revenue
$14.2B
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
10%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Revenue
AU$87.3m
CAGR 3-Years
31%
CAGR 5-Years
25%
CAGR 10-Years
42%
Telix Pharmaceuticals Ltd
ASX:TLX
Revenue
AU$502.5m
CAGR 3-Years
359%
CAGR 5-Years
381%
CAGR 10-Years
N/A

See Also

What is Patrys Ltd's Revenue?
Revenue
1.7m AUD

Based on the financial report for Dec 31, 2023, Patrys Ltd's Revenue amounts to 1.7m AUD.

What is Patrys Ltd's Revenue growth rate?
Revenue CAGR 10Y
9%

Over the last year, the Revenue growth was -52%. The average annual Revenue growth rates for Patrys Ltd have been 25% over the past three years , 27% over the past five years , and 9% over the past ten years .